Market Samachar

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s - CNBC

Read full article on CNBC ↗

Market Samachar is a news aggregator. This article was originally published by CNBC. Tap the button above to read the full story on their site.

• INDIAN Tanvi Exports files for IPO: 5 key highlights from gold jewellery maker’s DRHP mint - markets
• INDIAN Parliamentary panel may recommend govt for action on monitoring crypto Share Market Today
• CRYPTO Chainalysis Used AI to Trace the $387M Bitget Hack Back to North Korea Decrypt
• CRYPTO OpenAI Banned PewDiePie Twice While He Built Ajax, an Uncensored AI That Will Run on Your PC Decrypt
• CRYPTO Trump Is Hosting Yet Another Meme Coin Dinner: Here Are the Details Decrypt
• INDIAN India Summons Pakistan Diplomat Over 'Continued' Cross-Border Infiltration NDTV Profit - Latest
• INDIAN Shai Hope's Unbeaten 162 Powers West Indies To 5-Wicket Win Over India In 3rd ODI NDTV Profit - Latest
• INDIAN Dino Morea Questioned By Mumbai EOW In Mithi River Case Over Alleged Rs 65.54 Crore Loss NDTV Profit - Latest

More from Market Samachar

• Fed's Kashkari says inflation is 'still too high' even after softer-than-expected PCE data, labor market is 'pretty good' Finance
• The AI telling farmers when to harvest BBC News
• Vape prices to rise as new tax takes effect BBC News
• Vape tax comes into effect - but prices won't rise yet BBC News
• David Ellison names Ynon Kreiz co-CEO of Paramount and Warner Bros. Discovery Business News